Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 September 2020 | Story Lacea Loader

 


The South African Economy: 'Post-COVID-19, Post-Crisis'


As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the 3rd UFS Thought-Leader Series as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal and in collaboration with Vrye Weekblad


This year, higher-education institutions globally are situated within a challenging context of COVID-19. Aware of, and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and offer innovative solutions that will impact the lives of people nationally and globally to help them understand and adapt to a new world order. 

Against this background and context, this year’s debates focus on Post-COVID-19, Post-Crisis with Health and Modelling, the Economy, Politics and Predictions for 2021 as the sub-themes. Placed within a COVID-19 context, and in lieu of the Free State Arts Festival, the series will be presented virtually, in the form of one webinar per month, from August 2020 to November 2020. 

Second webinar presented on 23 September 2020

The South African economy was already in the doldrums before the COVID-19 crisis. Recent data from the NIDS-CRAM study suggests that as many as 3 million people might have lost their jobs as a result of the lockdown. In addition, the government's debt burden has deteriorated. What are the prospects for the South African economy post-COVID-19, post-Crisis?

 
Date: 23 September 2020
Topic: The South African Economy: Post-COVID-19, Post-Crisis
Time: 11:00-12:30

RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za by 18 September 2020 

Facilitator:

Editor: Vrye Weekblad 
Biography

Introduction and welcome:

Rector and Vice-Chancellor, UFS

Panellists:

Chairperson: Old Mutual Limited
Biography

Ms Ann Bernstein
Executive Director, Centre for Development and Enterprise (CDE)

Editor-in-Chief of City Press
Biography

 


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept